Anand Bhaskar — SEC insider filings
SEC reporting owner CIK 1890784. 18 insider filings on record with FilingPulse; latest filed 2026-10-14.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2022-01-05 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 5,223 shares, $554,334 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 2,343 shares @ $102.11 ($239,248) in REATA PHARMACEUTICALS INC, filed 2023-06-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REATA PHARMACEUTICALS INC (RETA) | SVP, Chief Accounting Officer | 10 | — | 8 legs · 5,223 sh · $554,334 | 13 |
| Summit Therapeutics Inc. (SMMT) | Chief Accounting Officer | 8 | — | — | 9 |
Insider filings — Anand Bhaskar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-14 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-01-12 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 30,000 (derivative) | EDGAR |
| 2025-10-23 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 26,680 @ $18.74 | EDGAR |
| 2025-09-19 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 50,000 (derivative) | EDGAR |
| 2025-05-01 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 600,000 (derivative) · Grant/award (A): 75,000 (derivative) | EDGAR |
| 2025-01-14 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 75,000 (derivative) | EDGAR |
| 2024-09-13 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 22,026 @ $22.70 | EDGAR |
| 2024-04-04 | 4 | Summit Therapeutics Inc. (SMMT) | Grant/award (A): 600,000 (derivative) | EDGAR |
| 2023-09-26 | 4 | REATA PHARMACEUTICALS INC (RETA) | Disposition to issuer (D): 24,089 · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 23,438 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 33,500 (derivative) | EDGAR |
| 2023-09-07 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 406 @ $169.20 | EDGAR |
| 2023-08-17 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 193 @ $169.06 · Sale (S): 210 @ $168.42 | EDGAR |
| 2023-06-16 | 4 | REATA PHARMACEUTICALS INC (RETA) | Option exercise (M): 1,562 @ $27.32 · Sale (S): 2,343 @ $102.11 · Option exercise (M): 1,562 (derivative) @ $0 | EDGAR |
| 2023-05-17 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 950 @ $85.98 · Sale (S): 136 @ $81.10 | EDGAR |
| 2023-03-08 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 165 @ $84.58 | EDGAR |
| 2023-03-06 | 4 | REATA PHARMACEUTICALS INC (RETA) | Sale (S): 820 @ $87.47 | EDGAR |
| 2023-03-02 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 3,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 8,250 @ $0 · Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | REATA PHARMACEUTICALS INC (RETA) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-01-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1890784 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs